The Hunter
Syndrome Market is expected to grow with CAGR of 7.5% in the coming years in
the 7MM.
Occurring in approximately 1
in 100,000 to 1 in 170,000 male births, Hunter Syndrome, is an X-linked
disorder, of carbohydrate metabolism that occurs almost exclusively in males,
with females as the carriers of the diseases. Hunter Syndrome, also known as Mucopolysaccharidosis
type II (MPS II), is an Iduronate 2-sulfatase (I2S) deficiency, which is an
enzyme responsible for breaking down complex sugar molecules in the body. Deficiency or lack of the enzyme results in
an abundance of complex molecules, ultimately leading to progressive and
permanent damage to the t...
